Untreated Adult Acute Myeloid Leukemia
Adult Acute Myeloid Leukemia in Remission
Recurrent Adult Acute Myeloid Leukemia

Untreated Adult Acute Myeloid Leukemia

Standard treatment of untreated adult acute myeloid leukemia (AML) during the remission induction phase depends on the subtype of AML and may include the following:

• Combination chemotherapy.
• High-dose combination chemotherapy.
• Low- dose chemotherapy.
• Stem cell transplant using donor stem cells.
• All-trans retinoic acid (ATRA) plus chemotherapy.
• Intrathecal chemotherapy.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with untreated adult acute myeloid leukemia.

Standard treatment of adult AML during the remission phase depends on the subtype of AML and may include the following:

• Combination chemotherapy.
• High-dose chemotherapy, with or without radiation therapy, and stem cell transplant using the patient's stem cells.
• High-dose chemotherapy and stem cell transplant using donor stem cells.
• A clinical trial of arsenic trioxide.

Information about ongoing clinical trials is available from the NCI Web site.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with adult acute myeloid leukemia in remission.

There is no standard treatment for recurrent adult AML. Treatment depends on the subtype of AML and may include the following:

• Combination chemotherapy.
• Biologic therapy with monoclonal antibodies.
• Stem cell transplant.
• Arsenic trioxide therapy.

Check for clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent adult acute myeloid leukemia.

Back to Top

< Previous Section  |  Next Section >